While there have been significant strides in the development of drugs for rare diseases over the past few decades, only 5% of rare diseases have FDA-approved tr...
Continue reading
In the most recent episode of The Genetics Podcast, Patrick speaks with Dr. Madhuri Hegde, SVP and Chief Scientific Officer at Revvity. Madhuri’s work has helpe...
Continue reading
.png)
In a recent episode of The Genetics Podcast, Patrick Short sits down with Dr. Euan Ashley, Chair of Medicine at Stanford University, author of The Genome Odysse...
Continue reading
In a recent episode of The Genetics Podcast, Patrick spoke with Kent Rogers, CEO of EveryONE Medicines, about the future of individualized medicines, especially...
Continue reading
Precision medicine has the potential to transform how we understand and treat autoimmune and inflammatory diseases, but only if we can align innovation with inf...
Continue reading
The way we treat autoimmune and inflammatory diseases is undergoing a fundamental shift. These conditions are deeply heterogeneous. Patients with the same diagn...
Continue reading
Podcast recap: Matt Burgess on genetic counseling, ethics in rare disease, and demystifying genetics
In the most recent episode of The Genetics Podcast, Patrick sits down with fellow podcaster and genetic counselor Matt Burgess. Matt is the host of Demystifying...
Continue reading
Autoimmune diseases include more than 80 conditions defined by immune system dysfunction in which the body mistakenly attacks healthy tissue. Treating autoimmun...
Continue reading
Despite growing momentum behind precision medicine, autoimmune and inflammatory diseases remain some of the most underserved areas in healthcare. Affecting an e...
Continue reading
In a recent episode of The Genetics Podcast, Patrick spoke with Dr. Sal Rico, Chief Medical Officer at Encoded Therapeutics. Having worked across small molecule...
Continue reading